AKILI INC (AKLI) Stock Price, Quote, News and Overview
NASDAQ:AKLI - Nasdaq - US00974B1070 - Common Stock - Currency: USD
AKLI Quote, Performance and Key Statistics
NASDAQ:AKLI (7/1/2024, 8:18:36 PM)
0.432
0 (-0.62%)
The current stock price of AKLI is 0.432 USD. In the past month the price increased by 2.71%. In the past year, price decreased by -63.7%.
AKLI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 36.16 | 36.69B | ||
| DOCS | DOXIMITY INC-CLASS A | 56.26 | 13.51B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 7.27B | ||
| CERT | CERTARA INC | 33.74 | 2.12B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.97B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 15.09 | 1.84B | ||
| PHR | PHREESIA INC | N/A | 1.63B | ||
| SDGR | SCHRODINGER INC | N/A | 1.61B | ||
| EVH | EVOLENT HEALTH INC - A | 16.3 | 1.25B | ||
| HSTM | HEALTHSTREAM INC | 50.43 | 996.84M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 983.14M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 14.51 | 764.83M |
Related stock screener links
About AKLI
Company Profile
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. The company is headquartered in Boston, Massachusetts and currently employs 66 full-time employees. The company went IPO on 2021-06-30. The firm is focused on developing and commercializing technologies designed to directly target the physiology of the brain. The Company’s software-based medicine is designed to directly target brain function and is delivered through engaging consumer entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain. The Company’s products include EndeavorRx, Selective Stimulus Management Engine (SSME), Body Brain Trainer (BBT) and Spatial Navigation (SNAV) Engine. EndeavorRx product is measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. SSME is specifically engineered to target and activate the systems in the brain that play a key role in attention function.
Company Info
AKILI INC
71 Commercial Street, Mailbox 312
Boston MASSACHUSETTS US
Employees: 66
Company Website: https://www.akiliinteractive.com/
Phone: 16174560597
AKILI INC / AKLI FAQ
What is the stock price of AKILI INC today?
The current stock price of AKLI is 0.432 USD. The price decreased by -0.62% in the last trading session.
What is the ticker symbol for AKILI INC stock?
The exchange symbol of AKILI INC is AKLI and it is listed on the Nasdaq exchange.
On which exchange is AKLI stock listed?
AKLI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AKILI INC stock?
6 analysts have analysed AKLI and the average price target is 0.66 USD. This implies a price increase of 53.47% is expected in the next year compared to the current price of 0.432. Check the AKILI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AKILI INC worth?
AKILI INC (AKLI) has a market capitalization of 34.01M USD. This makes AKLI a Nano Cap stock.
How many employees does AKILI INC have?
AKILI INC (AKLI) currently has 66 employees.
What are the support and resistance levels for AKILI INC (AKLI) stock?
AKILI INC (AKLI) has a support level at 0.41 and a resistance level at 0.43. Check the full technical report for a detailed analysis of AKLI support and resistance levels.
Is AKILI INC (AKLI) expected to grow?
The Revenue of AKILI INC (AKLI) is expected to grow by 94.59% in the next year. Check the estimates tab for more information on the AKLI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AKILI INC (AKLI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AKLI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AKLI, evaluating the profitability, health, valuation and growth aspects
- AKILI INC (AKLI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AKILI INC (AKLI) Sales and EPS estimates to see what analysts future expectations are.
- AKILI INC (AKLI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AKILI INC (AKLI) Insider and Institutional Ownership to learn about the owners and their transactions.
- AKILI INC (AKLI) Stock Chart to make your own analysis
- AKILI INC (AKLI) Latest news and press-releases to stay up to date.
Does AKILI INC (AKLI) stock pay dividends?
AKLI does not pay a dividend.
When does AKILI INC (AKLI) report earnings?
AKILI INC (AKLI) will report earnings on 2024-08-08, after the market close.
What is the Price/Earnings (PE) ratio of AKILI INC (AKLI)?
AKILI INC (AKLI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.6).
AKLI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AKLI. When comparing the yearly performance of all stocks, AKLI turns out to be only a medium performer in the overall market: it outperformed 53.94% of all stocks.
AKLI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AKLI. The financial health of AKLI is average, but there are quite some concerns on its profitability.
AKLI Financial Highlights
Over the last trailing twelve months AKLI reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS decreased by -242.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -72.07% | ||
| ROE | -96.7% | ||
| Debt/Equity | 0.08 |
AKLI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to AKLI. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 19.97% and a revenue growth 94.59% for AKLI